| # | Aladdin ID | Assay Type | Description | Organism | Compounds | Reference | BAO Format | Source | |
|---|---|---|---|---|---|---|---|---|---|
| 1. | ALA930565 | F | Growth inhibition of human HepG cells | Homo sapiens | 12 | ALA1142263 | cell-based format | Scientific Literature | |
| 2. | ALA930566 | F | Growth inhibition of human PANC1 cells | Homo sapiens | 12 | ALA1142263 | cell-based format | Scientific Literature | |
| 3. | ALA930567 | F | Growth inhibition of human CEM cells | Homo sapiens | 12 | ALA1142263 | cell-based format | Scientific Literature | |
| 4. | ALA930568 | B | Inhibition of NF-kappaB-mediated transcription in human HepG cells | Homo sapiens | 12 | ALA1142263 | cell-based format | Scientific Literature | |
| 5. | ALA930569 | B | Inhibition of CRE-mediated transcription in human HepG cells | Homo sapiens | 12 | ALA1142263 | cell-based format | Scientific Literature | |
| 6. | ALA930570 | B | Inhibition of AP1-mediated transcription in human HepG cells | Homo sapiens | 12 | ALA1142263 | cell-based format | Scientific Literature | |
| 7. | ALA930571 | B | Inhibition of GRE-mediated transcription in human HepG cells | Homo sapiens | 12 | ALA1142263 | cell-based format | Scientific Literature | |
| 8. | ALA965965 | F | Cytotoxicity against drug-resistant human KB-3-1 cells by MTS/PMS assay | Homo sapiens | 8 | ALA1150633 | cell-based format | Scientific Literature | |
| 9. | ALA965966 | F | Cytotoxicity against multidrug-resistant human KBV1 cells by MTS/PMS assay | Homo sapiens | 8 | ALA1150633 | cell-based format | Scientific Literature | |
| 10. | ALA1006044 | F | Cytotoxicity against human HONE1 at 10 uM after 3 days by MTS reduction assay | Homo sapiens | 3 | ALA1141750 | assay format | Scientific Literature | |
| 11. | ALA1006045 | F | Cytotoxicity against human NUGC at 10 uM after 3 days by MTS reduction assay | Homo sapiens | 3 | ALA1141750 | cell-based format | Scientific Literature | |
| 12. | ALA1040691 | F | NOVARTIS: Inhibition of Plasmodium falciparum 3D7 (drug-susceptible) proliferation in erythrocyte-based infection assay | Plasmodium falciparum | 5,614 | ALA1156829 | organism-based format | Novartis Malaria Screening | |
| 13. | ALA1040692 | F | NOVARTIS: Inhibition of Plasmodium falciparum W2 (drug-resistant) proliferation in erythrocyte-based infection assay | Plasmodium falciparum | 5,614 | ALA1156829 | organism-based format | Novartis Malaria Screening | |
| 14. | ALA1040693 | T | NOVARTIS: Cytotoxicity against human hepatocellular carcinoma cell line (Huh7) | Homo sapiens | 5,614 | ALA1156829 | cell-based format | Novartis Malaria Screening | |
| 15. | ALA1040694 | F | NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested. | 5,614 | ALA1156829 | assay format | Novartis Malaria Screening | ||
| 16. | ALA1105016 | F | Cytotoxicity against human HeLa cells after 48 hrs by WST8 colorimetric assay | Homo sapiens | 8 | ALA1154798 | cell-based format | Scientific Literature | |
| 17. | ALA1105017 | F | Cytotoxicity against human ACC-MESO1 cells after 48 hrs by WST8 colorimetric assay | Homo sapiens | 8 | ALA1154798 | cell-based format | Scientific Literature | |
| 18. | ALA1960679 | F | Antiproliferative activity against human HL60 cells after 72 hrs by SRB assay | Homo sapiens | 34 | ALA1955742 | cell-based format | Scientific Literature | |
| 19. | ALA1960683 | F | Antiproliferative activity against human A549 cells after 72 hrs by MTT assay | Homo sapiens | 38 | ALA1955742 | cell-based format | Scientific Literature | |
| 20. | ALA2150330 | F | Growth inhibition in human MCF7 cells after 72 hrs by alamar blue assay | Homo sapiens | 5 | ALA2146474 | cell-based format | Scientific Literature |
The page will load shortly, Thanks for your patience!